https://doi.org/10.1097/js9.0000000000000193
Y
Yasheng Zhu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
690
Citations
14
h-index
18
i10-index
Yasheng Zhu is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Prostate Cancer Treatment and Research & Immunotherapy and Immune Responses. The author has an h-index of 14, co-authored 34 publications.
ORCID: 0009-0009-6843-1433Papers by this author
worksRobotic-assisted versus laparoscopic radical prostatectomy for prostate cancer: the first separate systematic review and meta-analysis of randomised controlled trials and non-randomised studies
2023 · International Journal of Surgery · 43 citations
ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesis
2024 · Leukemia · 9 citations
https://doi.org/10.1038/s41375-024-02500-7
Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma
2023 · Scientific Reports · 7 citations
https://doi.org/10.1038/s41598-023-38914-z
ASO Therapy Targeting STAU2 to Inhibit Pancreatic Ductal Adenocarcinoma Progression and Metastasis by Regulating the PALLD‐Mediated EMT Signaling Pathway
2025 · Advanced Science · 0 citations
https://doi.org/10.1002/advs.202506718
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat